Ignite Creation Date:
2024-05-05 @ 11:26 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01334515
Status:
COMPLETED
Last Update Posted:
2019-10-21
First Post:
2011-04-12
Brief Title:
Biological Therapy Sargramostim and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Organization Data
Organization:
Childrens Oncology Group
Class:
NETWORK
Study ID:
ANBL1021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |